# OnCo record doxifluridine (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/doxifluridine/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "doxifluridine" ;
  schema:name "Doxifluridine"@en ;
  schema:alternateName "5'-Deoxy-5-fluorouridine"@en, "5'-DFUR"@en, "Furtulon" ;
  schema:description "Doxifluridine is an oral fluorouracil prodrug approved in Japan in 1987 and used in China and Korea for stomach, bowel and breast cancers; capecitabine, which the body turns into doxifluridine, later carried the same idea to the rest of the world."@en ;
  schema:url <https://onco.cc/drugs/doxifluridine/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Doxifluridine> ;
  schema:citation <https://en.wikipedia.org/wiki/Doxifluridine>, <https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL1200953> ;
  onco:status "established" ;
  onco:tag "gap-fill", "chembl-universe" ;
  onco:modality "Oral fluoropyrimidine prodrug" ;
  onco:cancers <https://onco.cc/cancers/gastric/>, <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/breast-hr-positive/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:targets <https://onco.cc/targets/tyms/> ;
  onco:drugs <https://onco.cc/drugs/capecitabine/>, <https://onco.cc/drugs/fluorouracil/> ;
  onco:trials <https://onco.cc/trials/nct00858429/> .